Cystic Fibrosis Trial, Recruiting (NCT07629986)

Cystic Fibrosis Trial, Recruiting NCT07629986 Sponsor: Fondation Ildys Condition: Cystic Fibrosis

Printed from Voxsanity (voxsanity.com.au) — NCT07629986 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cystic Fibrosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with cystic fibrosis, confirmed by a sweat test and/or genetic testing
You have been taking the medication elexacaftor/tezacaftor/ivacaftor (also known as ETI or Kaftrio/Trikafta) for at least 3 months
You are 12 years old or older
You (and your parent or legal guardian, if you are under 18) have been informed about the trial and do not object to taking part
Your doctor has decided you need antibiotic treatment for a flare-up of your lung condition or a chest infection
You are covered by a social security or health insurance system

Who may not be able to join:

You have had a lung transplant or a heart-lung transplant
You are currently under a legal guardianship or curatorship arrangement (confirm with trial site)
You are pregnant or currently breastfeeding

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33298293447

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07629986

Sponsor: Fondation Ildys

Phase: Not Applicable

Status: Recruiting

Condition: Cystic Fibrosis

Trial contact: +33298293447

More information: https://clinicaltrials.gov/study/NCT07629986

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with cystic fibrosis, confirmed by a sweat test and/or genetic testing
You have been taking the medication elexacaftor/tezacaftor/ivacaftor (also known as ETI or Kaftrio/Trikafta) for at least 3 months
You are 12 years old or older
You (and your parent or legal guardian, if you are under 18) have been informed about the trial and do not object to taking part
Your doctor has decided you need antibiotic treatment for a flare-up of your lung condition or a chest infection
You are covered by a social security or health insurance system

Who may not be able to join:

You have had a lung transplant or a heart-lung transplant
You are currently under a legal guardianship or curatorship arrangement (confirm with trial site)
You are pregnant or currently breastfeeding

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fondation Ildys

Registry

ClinicalTrials.gov

Start date

19 March 2026

Est. completion

1 March 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Pharmacokinetic profiles of antibiotics during pulmonary exacerbation treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov